PROPHYLAXIS AND THERAPY OF VENTRICULAR-FIBRILLATION - BRETYLIUM REVIEWED AND LIDOCAINE REFUTED

被引：13

作者：

BACANER, M

机构：

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 1983年 / 4卷 / 02期

关键词：

D O I：

10.1016/0167-5273(83)90128-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：133 / 152

页数：20

共 28 条

[1]

ALLEN J, 1969, BR J PHARM CHEMOTHER, V37, P526

[2] KINETICS OF ANTIFIBRILLATORY EFFECTS OF BRETYLIUM - CORRELATION WITH MYOCARDIAL DRUG CONCENTRATIONS [J].

ANDERSON, JL ;

PATTERSON, E ;

CONLON, M ;

PASYK, S ;

PITT, B ;

LUCCHESI, BR .

AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (04) :583-592

[3] BRETYLIUM TOSYLATE FOR SUPPRESSION OF INDUCED VENTRICULAR FIBRILLATION [J].

BACANER, M .

AMERICAN JOURNAL OF CARDIOLOGY, 1966, 17 (04) :528-&

[4]

BACANER M, 1979, BRETYLIUM TOSYLATE C, P7

[5] SUPPRESSION OF VENTRICULAR-FIBRILLATION AND POSITIVE INOTROPIC ACTION OF BETHANIDINE SULFATE, A CHEMICAL ANALOG OF BRETYLIUM TOSYLATE THAT IS WELL ABSORBED ORALLY [J].

BACANER, MB ;

HOEY, MF ;

MACRES, MG .

AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (01) :45-55

[6] QUANTITATIVE COMPARISON OF BRETYLIUM WITH OTHER ANTIFIBRILLATORY DRUGS [J].

BACANER, MB .

AMERICAN JOURNAL OF CARDIOLOGY, 1968, 21 (04) :504-&

[7] BRETYLIUM TOSYLATE FOR SUPPRESSION OF VENTRICULAR FIBRILLATION AFTER EXPERIMENTAL MYOCARDIAL INFARCTION [J].

BACANER, MB ;

SCHRIENEMACHERS, D .

NATURE, 1968, 220 (5166) :494-+

[8]

BENNETT MA, 1970, LANCET, V2, P909

[9]

BUCKLEY JJ, 1971, ANESTH ANALG, V50, P487

[10]

CARDINAL R, 1978, J PHARMACOL EXP THER, V204, P159

← 1 2 3 →